Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of 500-mg Mebendazole Chewable Formulation in Children
NCT01173562Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2010
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mebendazole in soil-transmitted helminth infection (STH), sponsored by Johnson & Johnson. Primary endpoint: Number, severity, relationship to study drug, and type of adverse events reported at Day 3. Started Feb 2010; status: completed.
02
Drugs
mebendazole
03
Conditions
soil-transmitted helminth infection (STH)
Beyond the preview
Go deeper on NCT01173562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173562.